Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea

NCT00875875 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped No study population in Mexico (H1N1). Study withdrawn from IRB consideration.

Conditions

Interventions

Sponsor

The University of Texas Health Science Center, Houston